Development of mRNA Vaccine Candidates for Pandemic Influenza
- Optimising design of different HA candidates
- Unravelling in vivo proof of concept data for an mRNA influenza vaccine
- Demonstrating scaling up and process development methods
London - Dec 6th - 8th 2025